Home6855 • HKG
add
Ascentage Pharma Group International
Previous close
$52.00
Day range
$50.80 - $53.15
Year range
$31.35 - $95.35
Market cap
19.43B HKD
Avg Volume
2.15M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 170.21M | 116.96% |
Operating expense | 485.67M | 36.87% |
Net income | -326.00M | -14.70% |
Net profit margin | -191.53 | 47.13% |
Earnings per share | — | — |
EBITDA | -309.12M | -16.99% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.47B | 95.02% |
Total assets | 3.96B | 51.41% |
Total liabilities | 2.63B | 12.19% |
Total equity | 1.33B | — |
Shares outstanding | 370.67M | — |
Price to book | 14.57 | — |
Return on assets | -20.76% | — |
Return on capital | -24.83% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -326.00M | -14.70% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2009
Website
Employees
767
